Brenda Libby Coleman

Array ( [id] => 4145431 [patent_doc_number] => 06031102 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-29 [patent_title] => 'Optically active pyridonecarboxylic acid derivatives' [patent_app_type] => 1 [patent_app_number] => 9/055127 [patent_app_country] => US [patent_app_date] => 1998-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31169 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/031/06031102.pdf [firstpage_image] =>[orig_patent_app_number] => 055127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4288604 [patent_doc_number] => 06211196 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-03 [patent_title] => 'Benzyloxy-substituted, fused N-heterocycles, processes for their preparation, and their use as bradykinin receptor antagonists' [patent_app_type] => 1 [patent_app_number] => 9/048305 [patent_app_country] => US [patent_app_date] => 1998-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18619 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/211/06211196.pdf [firstpage_image] =>[orig_patent_app_number] => 048305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4216377 [patent_doc_number] => 06110909 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Benzoxazepine compounds, their production and use as lipid lowering agents' [patent_app_type] => 1 [patent_app_number] => 9/043265 [patent_app_country] => US [patent_app_date] => 1998-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21713 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 277 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/110/06110909.pdf [firstpage_image] =>[orig_patent_app_number] => 043265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4052169 [patent_doc_number] => 05932571 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-03 [patent_title] => 'Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) {1,4}diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases' [patent_app_type] => 1 [patent_app_number] => 9/036155 [patent_app_country] => US [patent_app_date] => 1998-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50098 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 753 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/932/05932571.pdf [firstpage_image] =>[orig_patent_app_number] => 036155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7964233 [patent_doc_number] => 06680311 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-20 [patent_title] => 'Cryptophycin compounds' [patent_app_type] => B1 [patent_app_number] => 09/029190 [patent_app_country] => US [patent_app_date] => 1998-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 88970 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/680/06680311.pdf [firstpage_image] =>[orig_patent_app_number] => 09029190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4208443 [patent_doc_number] => 06028089 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-22 [patent_title] => 'Phenylthio-oxazoline compounds and their use as pesticides' [patent_app_type] => 1 [patent_app_number] => 9/030489 [patent_app_country] => US [patent_app_date] => 1998-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9258 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/028/06028089.pdf [firstpage_image] =>[orig_patent_app_number] => 030489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4418047 [patent_doc_number] => 06194362 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-27 [patent_title] => 'Glass cleaning compositions containing blooming perfume' [patent_app_type] => 1 [patent_app_number] => 9/025229 [patent_app_country] => US [patent_app_date] => 1998-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9545 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 177 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/194/06194362.pdf [firstpage_image] =>[orig_patent_app_number] => 025229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4034857 [patent_doc_number] => 05994537 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Process for preparing azepinone compounds useful in the inhibition of ACE and NEP' [patent_app_type] => 1 [patent_app_number] => 9/023995 [patent_app_country] => US [patent_app_date] => 1998-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13421 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 685 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/994/05994537.pdf [firstpage_image] =>[orig_patent_app_number] => 023995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4145458 [patent_doc_number] => 06031104 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-29 [patent_title] => 'Pyridyl-1,2,4-thiadiazoles' [patent_app_type] => 1 [patent_app_number] => 9/022957 [patent_app_country] => US [patent_app_date] => 1998-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5613 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/031/06031104.pdf [firstpage_image] =>[orig_patent_app_number] => 022957 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4185305 [patent_doc_number] => 06150416 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Nanomolar, non-peptide inhibitors of cathepsin D' [patent_app_type] => 1 [patent_app_number] => 9/018226 [patent_app_country] => US [patent_app_date] => 1998-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 15 [patent_no_of_words] => 12829 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/150/06150416.pdf [firstpage_image] =>[orig_patent_app_number] => 018226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4239651 [patent_doc_number] => 06080735 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-27 [patent_title] => 'Estra-1,3,5(10)-trien derivatives, processes for their preparation and pharmaceutical compositions containing these compounds' [patent_app_type] => 1 [patent_app_number] => 8/750943 [patent_app_country] => US [patent_app_date] => 1998-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8342 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 341 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/080/06080735.pdf [firstpage_image] =>[orig_patent_app_number] => 750943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4220602 [patent_doc_number] => 06040331 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-21 [patent_title] => 'Nerve cell protective agents' [patent_app_type] => 1 [patent_app_number] => 9/011260 [patent_app_country] => US [patent_app_date] => 1998-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59228 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 496 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/040/06040331.pdf [firstpage_image] =>[orig_patent_app_number] => 011260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4210083 [patent_doc_number] => 06028192 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-22 [patent_title] => 'Process for the preparation of diacylimides' [patent_app_type] => 1 [patent_app_number] => 9/013756 [patent_app_country] => US [patent_app_date] => 1998-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1969 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/028/06028192.pdf [firstpage_image] =>[orig_patent_app_number] => 013756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4109561 [patent_doc_number] => 06022971 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-08 [patent_title] => 'Azetidines' [patent_app_type] => 1 [patent_app_number] => 9/013152 [patent_app_country] => US [patent_app_date] => 1998-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15276 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1718 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/022/06022971.pdf [firstpage_image] =>[orig_patent_app_number] => 013152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4223622 [patent_doc_number] => 06011032 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-04 [patent_title] => 'Heterocyclic compounds for treating myocardial ischemia' [patent_app_type] => 1 [patent_app_number] => 9/011207 [patent_app_country] => US [patent_app_date] => 1998-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19063 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 170 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/011/06011032.pdf [firstpage_image] =>[orig_patent_app_number] => 011207 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3924755 [patent_doc_number] => 05945415 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-31 [patent_title] => '(R)-5-bromo-N-(1-ethyl-4-methylhexahydr o-1H-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridinecarboxamide, process for producing the same and medicinal composition containing the same' [patent_app_type] => 1 [patent_app_number] => 9/000468 [patent_app_country] => US [patent_app_date] => 1998-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7288 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/945/05945415.pdf [firstpage_image] =>[orig_patent_app_number] => 000468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3950401 [patent_doc_number] => 05977367 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'N-aminoalkyldibenzofurancarboxamides; new dopamine receptor subtype specific ligands' [patent_app_type] => 1 [patent_app_number] => 9/005285 [patent_app_country] => US [patent_app_date] => 1998-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5102 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 220 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/977/05977367.pdf [firstpage_image] =>[orig_patent_app_number] => 005285 [rel_patent_id] =>[rel_patent_doc_number] =>)